We are trying to decide whether to sell to a strategic buyer who promises a high synergy-based multiple or a private equity group offering a lower platform multiple but a substantial equity rollover. How do we evaluate these valuation structures to determine which truly maximizes our long-term wealth?

Question

Tyler Smith · Accepted Answer

Evaluating a strategic buyer versus a financial sponsor comes down to understanding how they value your cash flow. A strategic buyer is looking for synergies. They want to integrate your business into their existing platform, which allows them to cut duplicate administrative costs and cross-sell to your customer base. Because of these post-close savings, strategic buyers can often pay a higher upfront multiple. A financial sponsor, like a private equity group, is buying your business as a platform or an add-on. They value your standalone operational efficiency and will often structure the deal with a rollover equity requirement, meaning you leave twenty to thirty percent of your equity in the business to capture a second payout when they exit. To maximize your long-term wealth, you must align the buyer type with your company strengths. If your business has a highly scalable operational system, a financial sponsor might offer a lower initial multiple but a massive upside on the rollover equity. If your business has unique proprietary technology but lacks a large sales force, a strategic buyer who can instantly scale your product through their distribution channel will offer the highest clean cash exit. Use your V/TO to clarify your long-term goals and determine which deal structure fits your personal exit timeline.